» Articles » PMID: 18971333

Crystal Structure of Poxvirus Thymidylate Kinase: an Unexpected Dimerization Has Implications for Antiviral Therapy

Overview
Specialty Science
Date 2008 Oct 31
PMID 18971333
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Unlike most DNA viruses, poxviruses replicate in the cytoplasm of host cells. They encode enzymes needed for genome replication and transcription, including their own thymidine and thymidylate kinases. Some herpes viruses encode only 1 enzyme catalyzing both reactions, a peculiarity used for prodrug activation to obtain maximum specificity. We have solved the crystal structures of vaccinia virus thymidylate kinase bound to TDP or brivudin monophosphate. Although the viral and human enzymes have similar sequences (42% identity), they differ in their homodimeric association and active-site geometry. The vaccinia TMP kinase dimer arrangement is orthogonal and not antiparallel as in human enzyme. This different monomer orientation is related to the presence of a canal connecting the edge of the dimer interface to the TMP base binding pocket. Consequently, the pox enzyme accommodates nucleotides with bulkier bases, like brivudin monophosphate and dGMP; these are efficiently phosphorylated and stabilize the enzyme. The brivudin monophosphate-bound structure explains the structural basis for this specificity, opening the way to the rational development of specific antipox agents that may also be suitable for poxvirus TMP kinase gene-based chemotherapy of cancer.

Citing Articles

Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs: A WEB prediction approach.

Duan H, Shi Q, Yue X, Zhang Z, Liu L, Wang Y PLoS One. 2024; 19(12):e0303501.

PMID: 39642129 PMC: 11623562. DOI: 10.1371/journal.pone.0303501.


Identification of the myxobacterial secondary metabolites Aurachin A and Soraphinol A as promising inhibitors of thymidylate kinase of the Monkeypox virus.

Ali Y, Khan A, Alanazi A, Abdikakharovich S, Shah J, Ren Z Mol Divers. 2024; 28(5):3349-3362.

PMID: 38183513 DOI: 10.1007/s11030-023-10764-x.


Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase.

Rabaan A, Alwashmi A, Mashraqi M, Alshehri A, Alawfi A, Alshengeti A Mol Divers. 2023; 28(5):2735-2748.

PMID: 37531040 DOI: 10.1007/s11030-023-10705-8.


Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.

Ajmal A, Mahmood A, Hayat C, Hakami M, Alotaibi B, Umair M Front Cell Infect Microbiol. 2023; 13:1159389.

PMID: 37313340 PMC: 10258308. DOI: 10.3389/fcimb.2023.1159389.


Current Insights into Diagnosis, Prevention Strategies, Treatment, Therapeutic Targets, and Challenges of Monkeypox (Mpox) Infections in Human Populations.

Patel M, Adnan M, Aldarhami A, Bazaid A, Saeedi N, Alkayyal A Life (Basel). 2023; 13(1).

PMID: 36676198 PMC: 9863601. DOI: 10.3390/life13010249.


References
1.
Resch W, Hixson K, Moore R, Lipton M, Moss B . Protein composition of the vaccinia virus mature virion. Virology. 2006; 358(1):233-47. DOI: 10.1016/j.virol.2006.08.025. View

2.
Neyts J, Verbeken E, De Clercq E . Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice. Antimicrob Agents Chemother. 2002; 46(9):2842-7. PMC: 127439. DOI: 10.1128/AAC.46.9.2842-2847.2002. View

3.
El Omari K, Solaroli N, Karlsson A, Balzarini J, Stammers D . Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design. BMC Struct Biol. 2006; 6:22. PMC: 1636055. DOI: 10.1186/1472-6807-6-22. View

4.
Topalis D, Collinet B, Gasse C, Dugue L, Balzarini J, Pochet S . Substrate specificity of vaccinia virus thymidylate kinase. FEBS J. 2005; 272(24):6254-65. DOI: 10.1111/j.1742-4658.2005.05006.x. View

5.
Lavie A, Konrad M, Brundiers R, Goody R, Schlichting I, Reinstein J . Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 A resolution: implications for catalysis and AZT activation. Biochemistry. 1998; 37(11):3677-86. DOI: 10.1021/bi9720787. View